Pages that link to "Q50307952"

The following pages link to Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target? (Q50307952):

Displaying 20 items.

• Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs (Q28074736) (← links)
• Exome Sequencing and the Management of Neurometabolic Disorders. (Q37171865) (← links)
• Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. (Q38853247) (← links)
• Precision medicine in genetic epilepsies: break of dawn? (Q38990891) (← links)
• Pharmacogenomics in epilepsy. (Q39084353) (← links)
• Prophylactic anticonvulsants in patients with primary glioblastoma. (Q46073319) (← links)
• Neurotransmitters and Sodium Channelopathies; Possible Link? (Q47132776) (← links)
• Diagnostic approach to neurotransmitter monoamine disorders: experience from clinical, biochemical, and genetic profiles. (Q48326568) (← links)
• The role of the clinician in the multi-omics era: are you ready? (Q49835278) (← links)
• Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review. (Q55259038) (← links)
• Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes (Q64040232) (← links)
• Novel SCN2A mutation in a family associated with juvenile-onset myoclonus: Case report (Q64113024) (← links)
• Immunotherapy by targeting of VGKC complex for seizure control and prevention of cognitive impairment in a mouse model of epilepsy. (Q64883716) (← links)
• Secondary Abnormal CSF Neurotransmitter Metabolite Profiles in a Pediatric Tertiary Care Centre (Q87968520) (← links)
• Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience (Q89425458) (← links)
• Muscle and brain sodium channelopathies: genetic causes, clinical phenotypes, and management approaches (Q90110243) (← links)
• Synaptic metabolism: a new approach to inborn errors of neurotransmission (Q90264494) (← links)
• Biallelic SCN2A Gene Mutation Causing Early Infantile Epileptic Encephalopathy: Case Report and Review (Q92794436) (← links)
• metPropagate: network-guided propagation of metabolomic information for prioritization of metabolic disease genes (Q97422435) (← links)
• Physical exercise and 5-hydroxytryptophan, a precursor for serotonin synthesis, reduce penicillin-induced epileptiform activity (Q99575810) (← links)